About

Don Barbieri has been with SPI Pharma since August of 2015 and is now Technical Development Manager – North America. He is responsible for managing SPI Pharma’s excipient line and drug delivery platforms which include Mannogem® (mannitol), Actimask® (taste-masked APIs), Pharmaburst® 500, Advantol® 300 and the Pharmasperse® 416 product lines.

Mr Barbieri has worked in the pharmaceutical industry for over 30 years with responsibilities in a number of different areas including manufacturing, technical services, and process and formulation development. Prior to joining SPI Pharma in 2015, he was with Patheon in Cincinnati, OH, US, as the Associate Director of Formulation and Process Development.

Barbieri is a graduate of the Rutgers College of Pharmacy in (NJ, US) and is currently a registered pharmacist in New Jersey, Wisconsin and Pennsylvania.

Contributions

#77 Jul2017 ONdrugDelivery SPI Pharma feautured

GI/ORAL

MEETING THE CHALLENGES OF PAEDIATRIC DOSING

Although paediatric drugs are traditionally administered in a liquid formulation, recent studies suggest that orally disintegrating mini-tablets may be a more accurate, convenient and less messy dosage form. Don Barbieri explores this method and reviews two case studies looking at whether quality standards can be met and the importance of taste in paediatric formulations.